CXCR4 knockdown by small interfering RNA abrogates breast tumor growth in vivo

@article{Lapteva2005CXCR4KB,
  title={CXCR4 knockdown by small interfering RNA abrogates breast tumor growth in vivo},
  author={Natalia Lapteva and An-Gang Yang and Denise E Sanders and Randall W Strube and Si-Yi Chen},
  journal={Cancer Gene Therapy},
  year={2005},
  volume={12},
  pages={84-89}
}
Breast cancer cells express the chemokine receptor CXCR4 and frequently metastasize to organs with an abundant source of the CXCR4 ligand, stromal cell-derived factor 1 (SDF-1). The chemokine receptor CXCR4 plays an active role in the metastasis of breast cancer. Here, we show that a small interfering RNA (siRNA) against CXCR4 effectively downregulates CXCR4 expression in human MDA-MB-231 breast cancer cells, leading to significant decrease in breast cancer cell invasion and adhesion. It was… Expand
Opposing roles of CXCR4 and CXCR7 in breast cancer metastasis
TLDR
CXCR4 mediating breast cancer invasion and CXCR7 impairing invasion but enhancing primary tumor growth through angiogenesis are found to play different roles in metastasis. Expand
Multiple functions of CXCL12 in a syngeneic model of breast cancer
TLDR
Therapies that boost CXCL12 levels at the primary tumor site may prove more effective in the treatment of metastatic breast cancer, and the need to consider carefully therapeutic strategies that block CxCL12 signaling is highlighted. Expand
A CXCR4 antagonist CTCE-9908 inhibits primary tumor growth and metastasis of breast cancer.
TLDR
Treatment with the CXCR4 antagonist CTCE-9908 significantly reduced metastasis as well as primary tumor growth in mouse models of breast cancer. Expand
Multiple functions of CXCL 12 in a syngeneic model of breast cancer
Background: A growing body of work implicates chemokines, in particular CXCL12 and its receptors, in the progression and site-specific metastasis of various cancers, including breast cancer. VariousExpand
Implications of CXCR4/CXCL12 Interaction for Cancer Stem Cell Maintenance and Cancer Progression
TLDR
The correlation of CX CR4 expression with cancer stage and patient outcome makes CXCR4 an important prognostic marker as well as a druggable target with great potential for tumor sensitization to anti-cancer therapies. Expand
SLITs suppress tumor growth in vivo by silencing Sdf1/Cxcr4 within breast epithelium.
TLDR
It is shown that loss of Slits, or their Robo1 receptor, in murine mammary gland or human breast carcinoma cells results in coordinate up-regulation of the Sdf1 and Cxcr4 signaling axis, specifically within mammary epithelium. Expand
The role of the chemokine receptor CXCR4 in EGFRvIII-expressing breast cancer
The ligand-independent, constitutively active Epidermal Growth Fact or Receptor (EGFR) variant, EGFRvIII, is a potent tumor-specific on ogene found in many human cancers, including breast cancer.Expand
G Protein Coupled Receptor Kinase 3 Regulates Breast Cancer Migration, Invasion, and Metastasis
TLDR
It is demonstrated that alterations inGRK3 expression levels in tumor cells directly affect migration and invasion in vitro and the establishment of distant metastasis in vivo, and that GRK3 dysregulation may play an important part in TNBC metastasis. Expand
Interfering with CXCR4 expression inhibits proliferation, adhesion and migration of breast cancer MDA-MB-231 cells
To investigate the effect and mechanism of the CXC chemokine receptor 4 (CXCR4) in the proliferation and migration of breast cancer, a short-hairpin RNA (shRNA) eukaryotic expression vector targetingExpand
Does Combination Immunotherapy with Human Monoclonal Antibodies Against HER2 and CXCR4 Augment Breast Cancer Killing in Vitro and in Vivo
TLDR
Assessment of the anti-tumor effects of combinational immunotherapy by targeting both CXCR4 and HER2 in vitro and in a nude mice breast cancer model to provide pre-clinical data that may ultimately aid in testing the hypothesis that additive or synergistic effects of Combinational treatment with anti-CX CR4 and anti-HER2 human Mabs may lead to an additive or synergy effect in human clinical trials of breast cancer. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 30 REFERENCES
Involvement of chemokine receptors in breast cancer metastasis
TLDR
It is reported that the chemokine receptors CXCR4 and CCR7 are highly expressed in human breast cancer cells, malignant breast tumours and metastases and their respective ligands CXCL12/SDF-1α and CCL21/6Ckine exhibit peak levels of expression in organs representing the first destinations of breast cancer metastasis. Expand
Multiple actions of the chemokine CXCL12 on epithelial tumor cells in human ovarian cancer.
TLDR
The chemokine CXCL12 may have multiple biological effects in ovarian cancer, stimulating cell migration and invasion through extracellular matrix, as well as DNA synthesis and establishment of a cytokine network in situations that are suboptimal for tumor cell growth. Expand
Expression of CXCR4 and CXCL12 (SDF‐1) in human prostate cancers (PCa) in vivo
TLDR
Investigations into the expression of CXCR4 and CXCL12 in humans using high‐density tissue microarrays constructed from clinical samples obtained from a cohort of over 600 patients demonstrate that CX CR4 protein expression is significantly elevated in localized and metastastic cancers. Expand
Expression of CXC chemokine receptor-4 enhances the pulmonary metastatic potential of murine B16 melanoma cells.
TLDR
CXCR4 plays a potentially important role in promoting organ-selective metastasis, possibly by stimulating tumor adhesion to microvascular endothelial cells and by enhancing the growth of tumor cells under stress. Expand
The chemokine receptor CXCR4 is required for outgrowth of colon carcinoma micrometastases.
TLDR
The results suggest that CXCR4 inhibitors have potential as anticancer agents to suppress outgrowth of micrometastases and that isolated metastatic cells are likely to require CX CR4 signals to initiate proliferation. Expand
Use of the stromal cell-derived factor-1/CXCR4 pathway in prostate cancer metastasis to bone.
TLDR
Results suggest that prostate cancers and perhaps other neoplasms may use the SDF-1/CXCR4 pathway to spread to bone. Expand
Chemokine receptor CXCR4 downregulated by von Hippel–Lindau tumour suppressor pVHL
TLDR
It is shown that the von Hippel–Lindau tumour suppressor protein pVHL negatively regulates CX CR4 expression owing to its capacity to target hypoxia-inducible factor (HIF) for degradation under normoxic conditions, resulting in HIF-dependent CXCR4 activation. Expand
CXCR4/CXCL12 expression and signalling in kidney cancer
TLDR
The genetic changes reported here should provide new insights into the developmental paths leading to tumour progression and may also aid the design of new approaches to therapeutic intervention. Expand
Down-regulation of CXCR4 by inducible small interfering RNA inhibits breast cancer cell invasion in vitro.
TLDR
It is shown that inducible knockdown of endogenous CXC chemokine receptor-4 (CXCR4) gene expression in breast cancer cells resulted in significant inhibition of breast cancer cell migration in vitro. Expand
A Possible Role for CXCR4 and Its Ligand, the CXC Chemokine Stromal Cell-Derived Factor-1, in the Development of Bone Marrow Metastases in Neuroblastoma1
TLDR
The possibility that neuroblastoma cells use a mechanism similar to that used by hemopoietic stem cells to home to the bone marrow and adhere to bone marrow stromal cells is evaluated and suggests that CXCR4 expression may be a general characteristic of neuro Blastoma cells. Expand
...
1
2
3
...